Cigna Evernorth — Revenue decreased by 7.3% to $58.44B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.9%, from $53.68B to $58.44B. Over 4 years (FY 2021 to FY 2025), Evernorth — Revenue shows an upward trend with a 15.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Growth in total revenue signals successful client acquisition and retention, whereas a decline suggests competitive pressure or contract churn.
This is the total top-line revenue for the health services segment, encompassing all pharmacy benefit management, home d...
Standard segment revenue metric used by all diversified healthcare companies.
ci_segment_evernorth_health_services_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $32.59B | $33.61B | $35.09B | $33.59B | $34.86B | $35.70B | $36.19B | $36.18B | $38.21B | $38.60B | $40.52B | $46.23B | $49.55B | $52.46B | $53.74B | $53.68B | $57.83B | $60.39B | $63.06B | $58.44B |
| QoQ Change | — | +3.1% | +4.4% | -4.3% | +3.8% | +2.4% | +1.4% | -0.0% | +5.6% | +1.0% | +5.0% | +14.1% | +7.2% | +5.9% | +2.5% | -0.1% | +7.7% | +4.4% | +4.4% | -7.3% |
| YoY Change | — | — | — | — | +7.0% | +6.2% | +3.1% | +7.7% | +9.6% | +8.1% | +12.0% | +27.8% | +29.7% | +35.9% | +32.6% | +16.1% | +16.7% | +15.1% | +17.3% | +8.9% |